Thyroid status is a key modulator of tumor oxygenation: Implication for radiation therapy

Radiation Research

Volumn 168, Issue 4, 2007, Pages 428-432

  Jordan, Bénédicte F ^a   Christian, Nicolas ^a   Crokart, Nathalie ^a   Grégoire, Vincent ^a   Feron, Olivier ^a   Gallez, Bernard ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Laboratory of Biomedical Magnetic Resonance   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTRIX; PROPYLTHIOURACIL; THYROID HORMONE; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CARBON DIOXIDE TENSION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HYPERTHYROIDISM; HYPOTHYROIDISM; LEG TUMOR; MOUSE; NONHUMAN; OXIMETRY; OXYGEN CONSUMPTION; OXYGENATION; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR; ANIMAL; METABOLISM; NEOPLASM; PHYSIOLOGY; RADIATION DOSE; THYROID GLAND;

MUS;

ANIMALS; MICE; NEOPLASMS; OXYGEN; OXYGEN CONSUMPTION; RADIATION TOLERANCE; THYROID GLAND;

EID: 35548981254     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0931.1     Document Type: Article

References (22)

1. J. H. Oppenheimer, H. L. Schwartz, C. N. Mariash, W. B. Kinlaw, N. C. Wong and H. C. Freake, Advances in our understanding of TH action at the cellular level. Endocr. Rev. 8, 288-308 (1987).
2. P. M. Yen, Physiological and molecular basis of TH action. Physiol. Rev. 81, 1097-1142 (2001).
3. A. Hercbergs, The thyroid gland as an intrinsic biologic response-modifier in advanced neoplasia - a novel paradigm. In Vivo 10, 245-247 (1996).
4. J. P. Shoemaker and R. K. Dagher, Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate. J. Natl. Cancer Inst. 62, 1575-1578 (1979).
5. M. S. Kumar, T. Chiang and S. D. Deodhar, Enhancing effect of thyroxine on tumor growth and metastases in syngeneic mouse tumor systems. Cancer Res. 39, 3515-3518 (1979).
6. R. M. Mason and M. K. Bansal, Different growth rates of swarm chondrosarcoma in Lewis and Wistar rats correlate with different thyroid hormone levels. Connect. Tissue Res. 16, 177-185 (1987).
7. S. Y. Mishkin, R. Pollack, M. A. Yalovsky, H. P. Morris and S. Mishkin, Inhibition of local and metastatic hepatoma growth and prolongation of survival after induction of hypothyroidism. Cancer Res. 41, 3040-3045 (1981).
8. C. Theodossiou, N. Skrepnik, E. G. Robert, C. Prasad, T. W. Axelrad, D. V. Schapira and J. D. Hunt, Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice. Cancer 86, 1596-1601 (1999).
9. B. Gustavsson, A. Hermansson, A. C. Andersson, L. Grimelius, J. Bergh, B. Westermark and N. E. Heldin, Decreased growth rate and tumour formation of human anaplastic thyroid carcinoma cells transfected with a human thyrotropin receptor cDNA in NMRI nude mice treated with propylthiouracil. Mol. Cell. Endocrinol. 121, 143-151 (1996).
10. A. Hercbergs and J. T. Leith, Spontaneous remission of metastatic lung cancer following myxedema coma - an apoptosis-related phenomenon? J. Natl. Cancer Inst. 85, 1342-1343 (1993).
11. M. Cristofanilli, Y. Yamamura, S. W. Kau, T. Bevers, S. Strom, M. Patangan, L. Hsu, S. Krishnamurthy, R. L. Theriault and G. N. Hortobagyi, Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103, 1122-1128 (2005).
12. F. B. Davis, H. Y. Tang, A. Shih, T. Keating, L. Lansing, A. Hercbergs, R. A. Fenstermaker, A. Mousa, S. A. Mousa and H. Y. Lin, Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res. 66, 7270-7275 (2006).
13. A. Hercbergs, F. Brok-Simoni, F. Holtzman, J. Bar-Am, J. Leith and H. Brenner, Erythrocyte gluthatione and tumor response to chemotherapy. Lancet 339, 1074-1076 (1992).
14. A. A. Hercbergs, L. K. Goyal, J. H. Suh, S. Lee, C. A. Reddy, B. H. Cohen, G. H. Stevens, S. K. Reddy, D. M. Peereboom and G. H. Barnett, Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study. Anticancer Res. 23, 617-626 (2003).
15. R. Gredilla, T. M. Lopez, M. Portero-Otin, R. Pamplona and G. Barja, Influence of hyper- and hypothyroidism on lipid peroxidation, unsaturation of phospholipids, glutathione system and oxidative damage to nuclear and mitochondrial DNA in mice skeletal muscle. Mol. Cell. Biochem. 221, 41-48 (2001).
16. J. E. Biaglow, Y. Manevich, D. Leeper, B. Chance, M. W. Dewhirst, W. T. Jenkins, S. W. Tuttle, K. Wroblewski, J. D. Glickson and S. M. Evans, MIBG inhibits respiration: Potential for radio- and hyperthermic sensitization. Int. J. Radiat. Oncol. Biol. Phys. 42, 871-876 (1998).
17. B. F. Jordan, V. Gregoire, R. J. Demeure, P. Sonveaux, O. Feron, J. A. O'Hara, V. P. Vanhulle, N. Delzenne and B. Gallez, Insulin increases the sensitivity of tumors to irradiation: Involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Res. 62, 3555-3561 (2002).
18. N. Crokart, K. Radermacher, B. F. Jordan, C. Baudelet, G. O. Cron, V. Gregoire, N. Beghein, C. Bouzin, O. Feron and B. Gallez, Tumor radiosensitization by antiinflammatory drugs: Evidence for a new mechanism involving the oxygen effect. Cancer Res. 65, 7911-7916 (2005).
19. H. Taper, G. W. Woolley, M. N. Teller and M. P. Lardis, A new transplantable mouse liver tumor of spontaneous origin. Cancer Res. 26, 143-148 (1966).
20. B. Gallez, C. Baudelet and B. F. Jordan, Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications. NMR Biomed. 17, 240-262 (2004).
21. B. Gallez, B. F. Jordan, C. Baudelet and P. D. Misson, Pharmacological modifications of the partial pressure of oxygen in murine tumors: Evaluation using in vivo EPR oximetry. Magn. Reson. Med. 42, 627-630 (1999).
22. P. Vaupel, Oxygenation of human tumors. Strahlenther. Onkol. 166, 377-286 (1990).